High circulating IGFBP-3 concentration predicts greater incidence of cardiovascular conditions including ischemic heart disease and congestive heart failure and high risk of cancer (Juul et al., 2002; Schumacher et al., 2010). Here, IGFBP3 is linked to cancer.